Kristen Nichols

CV Sciences earnings rise, but CEO says CBD confusion limiting growth

(This story has been updated to clarify that the CEO referred to state regulatory differences on CBD, not seizures of CBD.) CBD giant CV Sciences posted $10.2 million in profit last year, a big improvement from 2017, when the company lost roughly $4.9 million, according to the firm’s year-end fiscal report. The San Diego company, which […]

Read More

Report: FDA chief to resign, leaving CBD review in question

Just as the CBD industry was hoping to start work next month on the cannabinoid’s place in food, drugs and cosmetics, the head of the U.S. Food and Drug Administration chief is resigning. Dr. Scott Gottlieb, who told Congress last week that CBD can’t be added to consumer products, is leaving office in April, according […]

Read More

USDA plans webinar on hemp and the Farm Bill, invites comments

The U.S. Department of Agriculture (USDA) will hold a webinar to get public input on the 2018 Farm Bill and hemp production. All interested parties are welcome to provide comments during the March 13 session, hosted by the USDA’s Specialty Crops Program. Participants must register in advance, and those who wish to speak must submit written comments to [email protected] by […]

Read More

Earnings roundup: GW Pharmaceuticals awaiting big CBD drug sales as it reports losses

GW Pharmaceuticals, the drugmaker behind the only federally approved CBD product, is still losing money, though it says it’s happy with early sales of its seizure control drug Epidiolex. Last summer, Epidiolex became the first cannabis-derived treatment approved by the U.S. Food and Drug Administration, prompting the U.S. Drug Enforcement Administration to reschedule CBD under […]

Read More

North Dakota court says CBD status not a ‘matter of great public concern’

North Dakota’s highest court has decided not to rule on the legality of hemp-derived CBD, upholding a drug conviction for a vape-shop owner who sold CBD. The court said that the retailer, Falesteni A. Abu Hamda, should have made his CBD argument earlier instead of accepting the state’s case against him. Hamda was charged with seven drug […]

Read More

Congress to FDA: We need CBD answers by Friday

Saying that states need “immediate leadership” on CBD in foods, drugs and cosmetics, 12 members of Congress have asked the head of the U.S. Food and Drug Administration (FDA) to release updated guidance by Friday.

Read More

CBD advertisements removed from Alaska city’s buses

Advertising restrictions continue to affect the hemp and CBD industry, with one Alaska town removing CBD ads from city buses rather than face possible complaints about them. A borough in Fairbanks took down Aurora Apothecary ads on buses promoting CBD. The bus system said that no one complained about the ads, but pointed out they should […]

Read More

As CBD crackdown spreads, New York politician vows to halt ‘overreaction’

More restaurants and facilities nationwide report they can’t sell CBD anymore, even as an official in New York City vows to turn back the Big Apple’s crackdown on CBD use in eateries. In the past week, enforcement letters and product seizures spread to new jurisdictions, a response to December comments from the U.S. Food and Drug […]

Read More